Search Results 361-370 of 1072 for ai写作的网文,ai智能写作网址,ai制作网,ai降重免费网站,ai提示词中文网站,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

1. Publications - Kitty Y. Wu, M.D. - Mayo Clinic

   Porche K, Wu KY, Spinner RJ. Superficial peroneal to tibial nerve transfer for restoring plantar flexion in partial sciatic nerve injuries: illustrative ...

2. DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01) - Mayo Clinic

   The main objective of this study is to test the safety and effectiveness of DS-8201a for participants with HER2-expressing advanced colorectal cancer.

3. A Study to Test the Feasibility, Usability and Accuracy of a Smart Phone Food-Record App to Assess Dietary Intake in Patients Who Have Undergone Gastric Bypass Surgery - Mayo Clinic

   The purpose of this study is to assess the acceptability and accuracy of the smart phone food record App 'HealthWatch 360' in collecting food intake data from ...

4. Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC - Mayo Clinic

   The main purpose of the study is to evaluate safety and effectiveness of taletrectinib (also known as AB-106 or DS-6051b) monotherapy in the treatment of ...

5. NPPA Simulation Education for Surviving Sepsis and Safety evaluation of In Situ training. - Mayo Clinic

   About this study. This research aims to demonstrate the benefits and risks of introducing in situ education into the NPPA work environment.

6. Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia - Mayo Clinic

   The purpose of this study is to test any good and bad effects of adding the drug Blinatumomab to different doses of standard combination of chemotherapy drugs.

7. Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

   The objective of this study is to assess the safety and tolerability, including the maximum tolerated dose, of ASP2215 in subjects with relapsed or treatment- ...

8. Confirmatory Study of Topical HyBryte™ Vs. Placebo for the Treatment of CTCL (FLASH2) - Mayo Clinic

   The purpose of this study is to evaluate the use of HyBryte, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell ...

9. A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

10. A Study of MPDL3280A (Anti-PD-L1 Antibody) Combined with Carboplatin and Paclitaxel , and with or without Bevacizumab, for Patients who have Stage IV Non-Squamous Non-Small Cell Lung Cancer - Mayo Clinic

    A Study of MPDL3280A (Anti-PD-L1 Antibody) Combined with Carboplatin and Paclitaxel , and with or without Bevacizumab, for Patients who have Stage IV Non- ...